Irenic Capital Management LP Acquires New Shares in Integer Holdings Corporation $ITGR

Irenic Capital Management LP acquired a new stake in Integer Holdings Corporation (NYSE:ITGR) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,263,663 shares of the medical equipment provider’s stock, valued at approximately $99,109,000. Integer makes up 6.7% of Irenic Capital Management LP’s investment portfolio, making the stock its largest position. Irenic Capital Management LP owned about 3.61% of Integer as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of ITGR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Integer by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider’s stock worth $2,539,000 after buying an additional 837 shares in the last quarter. Millennium Management LLC increased its position in Integer by 2,408.8% during the first quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock worth $14,531,000 after buying an additional 118,224 shares in the last quarter. Jones Financial Companies Lllp increased its position in Integer by 79,888.9% during the first quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider’s stock worth $850,000 after buying an additional 7,190 shares in the last quarter. United Services Automobile Association purchased a new position in Integer during the first quarter worth $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Integer by 4.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider’s stock worth $12,900,000 after buying an additional 4,873 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Truist Financial raised their price target on Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Friday, February 20th. Citigroup raised their price target on Integer from $89.00 to $92.00 and gave the stock a “neutral” rating in a research report on Thursday, May 28th. Wells Fargo & Company raised their price target on Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday, February 20th. Raymond James Financial reissued an “outperform” rating and set a $101.00 price target on shares of Integer in a research report on Monday, February 23rd. Finally, Zacks Research downgraded Integer from a “hold” rating to a “strong sell” rating in a research report on Monday, May 11th. Four investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $98.71.

Integer Price Performance

ITGR stock opened at $89.70 on Thursday. Integer Holdings Corporation has a 52-week low of $62.00 and a 52-week high of $123.78. The stock’s fifty day simple moving average is $88.69 and its 200-day simple moving average is $84.61. The company has a quick ratio of 2.38, a current ratio of 3.75 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $3.05 billion, a price-to-earnings ratio of 22.37, a price-to-earnings-growth ratio of 2.18 and a beta of 0.66.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). Integer had a net margin of 7.64% and a return on equity of 12.83%. The firm had revenue of $439.58 million during the quarter, compared to analyst estimates of $426.48 million. During the same quarter in the previous year, the business posted $1.31 EPS. Integer’s revenue was up .5% compared to the same quarter last year. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Equities research analysts expect that Integer Holdings Corporation will post 6.04 EPS for the current year.

Integer Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.